Adaptimmune Therapeutics PLC

ADAPCIK 0001621227 · Every Form 4 filed by insiders at this issuer.

Filings

Latest Mar 18, 2024

Unique insiders

Showing

18 of 18

Page 1

Top insiders

Most active reporters at Adaptimmune Therapeutics PLC

18 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 18, 2024	Piccina Cintia Chief Commercial Officer	Holdings only	—	—	—
Jan 17, 2024	Rawcliffe Adrian Chief Executive Officer · Director	Holdings only	—	—	—
Jan 17, 2024	Norry Elliot Chief Medical Officer	Holdings only	—	—	—
Jan 17, 2024	Wood Gavin Chief Financial Officer	Holdings only	—	—	—
Jan 17, 2024	TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer	Holdings only	—	—	—
Jan 17, 2024	Brewer Joanna Elizabeth Chief Scientific Officer	Holdings only	—	—	—
Jan 17, 2024	Lunger John Chief Patient Supply Officer	Holdings only	—	—	—
Jan 17, 2024	Hege Kristen Director	Holdings only	—	—	—
Jan 17, 2024	Bertrand William C JR Chief Operating Officer	Holdings only	—	—	—
Jan 17, 2024	Bertrand William C JR Chief Operating Officer	SSale	13,599	$0.673	$9,152
Jan 17, 2024	Lunger John Chief Patient Supply Officer	SSale	12,805	$0.673	$8,618
Jan 17, 2024	Norry Elliot Chief Medical Officer	SSale	12,967	$0.673	$8,727
Jan 17, 2024	Rawcliffe Adrian Chief Executive Officer · Director	SSale	30,080	$0.673	$20,244
Jan 17, 2024	Behbahani Ali Director	Holdings only	—	—	—
Jan 12, 2024	Rawcliffe Adrian Chief Executive Officer · Director	SSale	17,257	$0.8541	$14,739
Jan 12, 2024	Norry Elliot Chief Medical Officer	SSale	7,799	$0.8541	$6,661
Jan 12, 2024	Lunger John Chief Patient Supply Officer	SSale	5,220	$0.8541	$4,458
Jan 12, 2024	Bertrand William C JR Chief Operating Officer	SSale	5,220	$0.8541	$4,458

Showing 1–18 of 18

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.